Stocks and major sectors traded mixed through midday as company-specific catalysts outweighed broader market direction. Intuitive Machines surged again after receiving an authorization to begin work on a multi-satellite communications program, while EyePoint Pharmaceuticals fell sharply after a late-stage trial did not meet its main objective. Meanwhile, gains in memory chip names were supported by remarks from the U.S. Commerce Secretary that the Trump administration opposes Apple buying Chinese memory chips.
Key takeaways
- Intuitive Machines jumped again for a fifth straight session after receiving an “authorization to proceed” for a $600 million multi-satellite communications infrastructure program.
- EyePoint Pharmaceuticals plunged about 70% after its Phase 3 trial of Duravyu failed to achieve its primary goal for wet age-related macular degeneration.
- Memory chip stocks rose as investors reacted to U.S. policy signals opposing Apple’s planned purchase of Chinese memory chips.
- Workday slid after a downgrade, a reversal from an outsized recent rally that followed reports of a potential buyout.
- On semiconductors and identity software, Wall Street calls drove moves, with Goldman initiating a buy on Onto Innovation and Deutsche Bank cutting Workday to hold.
What drove the biggest movers
Space and defense-linked optimism lifted Intuitive Machines. The company said it received an “authorization to proceed” from an unnamed customer to begin work on a $600 million, multi-satellite communications infrastructure program. The stock extended gains for a fifth day, building on an earlier jump after Intuitive disclosed its latest order backlog. For investors, the key focus was visibility on contract execution—particularly the progress implied by moving from deal disclosure to authorization to start work.
EyePoint Pharmaceuticals faced a sharp repricing after clinical results. Shares fell about 70% after Duravyu did not achieve the primary endpoint in a Phase 3 trial for wet age-related macular degeneration. In biotech, the primary endpoint failure typically drives fast downward revisions to expectations for regulatory pathways and commercial timing. The magnitude of the move reflected how binary trial results are for near-term sentiment and valuation.
Airline weakness continued in JetBlue. JetBlue shares dropped about 6% and were on pace for a seventh decline in nine sessions. The stock has lost 13% over the past six months, and Seaport Research Partners lowered its rating on the airline to neutral from buy. The ongoing pattern suggests investors are weighing earnings durability and demand outlook, with the downgrade reinforcing caution.
Analyst actions and policy signals reshaped sentiment
Semiconductor and industrial software names responded to fresh coverage and rating changes. Onto Innovation climbed about 5% after Goldman Sachs initiated coverage with a buy rating, according to FactSet. The stock has risen more than 120% this year, indicating investors have already been pricing a strong outlook; the initiation likely added institutional support rather than fundamentally changing the operating narrative overnight.
Workday fell as a downgrade came after a surge tied to deal chatter. Workday shares slipped about 4% after Deutsche Bank downgraded the stock to hold from buy, according to FactSet. The downgrade followed a run-up in which the shares had soared 40% since July 24. Last Thursday, Reuters reported that private equity firm Silver Lake was in talks to buy Workday, a development that helped drive a major one-day gain. In this context, investors appeared to treat the stock as increasingly dependent on a potential transaction outcome—making sentiment more sensitive to rating shifts.
SoFi gained marginally after new research coverage. SoFi Technologies edged higher after Piper Sandler initiated research coverage with an overweight rating. Analysts said the company’s current pricing offers an attractive entry point and pointed to a strong product portfolio addressing a growing total addressable market.
Okta steadied after an earlier bounce on a competitor-driven narrative. Okta gave back some early gains after a Wells Fargo upgrade to overweight from equal-weight. The bank argued that identity is becoming a spending priority for businesses, which could support growth in Okta’s security offerings.
Memory chips and corporate news fed sector moves
Memory chip stocks climbed on U.S. policy comments. Several chip names rose after U.S. Commerce Secretary Howard Lutnick told the Wall Street Journal in an interview that the Trump administration opposes Apple buying Chinese memory chips. Sandisk jumped 10%, Western Digital added 5%, Micron Technology gained 6%, and Seagate Technology was higher by 2%. For investors, the implication was a potential shift in procurement and market share dynamics, with policy potentially favoring domestic or non-China supply chains.
Intel advanced on insider buying. Intel shares rose nearly 4% after CEO Lip-Bu Tan bought more than 105,000 shares last week at $95 each, based on a late Friday Securities and Exchange Commission filing. Insider purchases can influence sentiment by signaling confidence, though investors typically weigh the transaction size and timing alongside broader fundamentals.
Alibaba rose on plans to sell an asset. Alibaba shares were up almost 1% after Reuters reported the company is set to sell its game development business. Reuters said Lingxi Games is expected to be sold for more than $2 billion to private equity firm Trustar Capital, citing a person familiar with the matter. Asset sales can be interpreted as portfolio reshaping and balance-sheet optimization, but investors generally watch for how proceeds translate into shareholder returns or reinvestment.
What to watch next
With stock moves heavily driven by single-name catalysts, investors may look for follow-through in execution on the contracts driving Intuitive Machines and for additional details around trial outcomes affecting EyePoint Pharmaceuticals. For broader markets, U.S. policy signals around semiconductors could remain a near-term driver for memory and supply-chain sentiment. Upcoming catalysts to monitor include further earnings updates, analyst changes, and closely watched U.S. economic and Federal Reserve communications that can sway interest-rate expectations and risk appetite.
